FDA: Draft Guidance Can Help Assess Credibility of Computational Modeling Used in Device Submissions
January 6, 2022 at 12:35 PM EST
A draft guidance issued by the FDA’s Center for Devices and Radiological Health (CDRH) can be used by medical device manufacturers to assess the credibility of the computational modeling and simulation (CM&S) data that they submit to the agency for their devices.
Computational models are being used with increasing frequency in various ways in device regulatory submissions... Read More
